
Despite market turbulence, the biotech sector has performed well due to breakthrough developments and inelastic demand for healthcare products and services.
Given this backdrop, investors could check out fundamentally sound stocks Amicus Therapeutics, Inc. (FOLD) and POINT Biopharma Global Inc. (PNT).